A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Robert Ballotti Paul Hofman Corine Bertolotto Jean-Philippe Lacour Philippe Bahadoran |
| Publication date | December 6, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |